Cognitive-behavioural therapy for the management of sickle cell disease pain: Identification and assessment of costs

Ethnicity and Health

Volumn 6, Issue 1, 2001, Pages 59-67

  Thomas, Veronica J ^a,d   Gruen, Reinhold ^b   Shu, Shu ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cognitive behaviour therapy; Economic evaluation; Sickle cell disease

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; CONTROLLED STUDY; COPING BEHAVIOR; COST EFFECTIVENESS ANALYSIS; DISTRESS SYNDROME; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PATIENT CARE; PSYCHOLOGICAL ASPECT; SICKLE CELL ANEMIA; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; COGNITIVE THERAPY; COSTS AND COST ANALYSIS; FEMALE; HUMANS; MALE; PAIN;

EID: 0035026882     PISSN: 13557858     EISSN: None     Source Type: Journal    
DOI: 10.1080/13557850123965     Document Type: Article

References (24)

1. Thomas VJ, Dixon AL & Milligan P. Cognitive-behaviour therapy for the management of sickle cell disease pain: an evaluation of a community-based intervention. Br J Health Psychol 1999; 4: 209-29.
2. Fuggle P, Shand PAX, Gill LJ & Davies SC. Pain, quality of life, and coping in sickle cell disease. Archives of Diseases in Childhood 1996; 75: 199-203.
3. Yardumian A. Setting the Scene. Paper presented at Haringey Healthcare Conference on sickle cell anaemia, October, Alexandra Palace, London, 1993.
4. Molock SD & Belgrave FZ. Depression and anxiety in patients with sickle cell disease: conceptual and methodological considerations. In: Nash KB, Ed. Psychosocial Aspects of Sickle Cell Disease: past, present, and future directions of research. New York: Haworth Press, 1994.
5. Streetly A. The cost implications of painful crises in South East London sickle cell disease patient population. Unpublished paper, 1995.
6. Hughes M & Konrad TR. Epilogue. In: Nash KB, Ed. Psychosocial Aspects of Sickle Cell Disease: past, present, and future directions of research. New York: Haworth Press, 1994.
7. Vichinsky EP, Johnson R & Lubin BH. Multidisciplinary approach to pain management in sickle cell disease. Am J Pediatric Hematology/Oncology 1982; 4(3): 328-32.
8. Turk DC & Michenbaum D. A cognitive-behavioural approach to pain management. In: Wall PD & Melzack R, Eds. Textbook of Pain. Edingburgh: Churchill Livingstone, 1994: 1337-48.
9. CIPFA. Personal social services statistics 195-6 actuals. The Chartered Institute of Public Finance and Accountancy. London: Statistical Information Service, 1997.
10. Graham B & McGregor K. What does a GP consultation cost? Br J General Practice 1997; 47: 170-72.
11. Bosanquet N, Franks P, Moffat C, Conolly M, Oldroyd M, Brown P, Greenhalgh R & McCollum C. Community leg ulcer clinics: cost-effectiveness. Health Trends 1997; 25: 146-48.
12. Efron B & Tibshirani RJ. An Introduction to the Bootstrap. New York: Chapman and Hall, 1993.
13. Lamping DL, Henderson L, Constantinovici N, Harris S, Gruen R, Roderick P, Brown E, Victor C, Normand C & Steriu A. The North Thames Dialysis Study (NTDS): the costs and benefits of dialysis for the elderly. Project report. North Thames Project No. SWG034, 1998.
14. Lambert CM, Hurst NP, Forbes JF, Lochhead A, Macleod M & Nuki G. Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation. BMJ 1998; 16: 965-9.
15. Tsevat J, Wong JB, Pauker SG & Steinberg MH. Neonatal screening for sickle cell disease: a cost-effectiveness analysis. J Pedriatrics 1991; 118(4): 546-54.
16. Davies SC, Cronin E, Gill M, Greengross P, Hickman M & Normand C. Screening for sickle cell disease and thalssaemia. Report for the Health Technology Assessment NHS R&D Programme, 1999.
17. Modell B & Anionwu E. Ethnicity and health: reviews of literature and guidance for purchasers in the areas of cardiovascular disease, mental health and haemoglobinopathies. Part 4 Guidelines for screening for haemoglobin disorders: service specifications for low and high prevalence DHAs (Abstract), 1996.
18. Brookoff D & Polomano R. Treating sickle cell pain like cancer pain. Annals of Internal Medicine 1992; 116: 364-8.
19. Yang YM, Shah AK, Watson M & Mankad VN. Comparison of costs to the health sector of comprehensive and episodic healthcare for sickle cell disease patients. Public Health Rep 1995; 110(1): 80-6.
20. Woods K, Karrison T, Koshy M, Patel A, Friedmann P & Cassel C. Hospital utilization patterns and costs for adult sickle cell patients in Illinois. Public Health Rep 1997; 112(1): 44-51.
21. Davis H, Moore RM Jr & Gergen PJ. Cost of hospitalisations associated with sickle cell disease in the United. Public Health Rep 1997; 112(1): 40-3.
22. Gil KM, Abrams MR, Phillips G & Keefe FJ. Sickle cell disease pain: relation of coping strategies to adjustment. J Consulting and Clinical Psychol 1989; 57(6): 725-31.
23. Gil KM, Abrams MR, Phillips G & Keefe FJ. Sickle cell disease pain: relation of coping strategies to adjustment. J Consulting and Clinical Psychol 1992; 57: 725-31.
24. Thomas VJ. Cognitive-behaviour therapy for the management of sickle cell disease pain: an evaluation of a community-based intervention. Unpublished Final Report for NHS Executive Department of Health, London, 1999.